Posted BY: Teresa | NwoReport

This article discusses the misconception surrounding placebo-controlled clinical trials and their application in testing vaccine safety. While most people associate placebo-controlled trials with drug testing, we argue that this standard is not consistently applied to vaccines. The debate was sparked by a Twitter exchange between pediatrician and vaccinologist Paul Offit and Aaron Siri, a lawyer from the Informed Consent Action Network (ICAN), regarding the use of placebos in vaccine trials.

Offit initially claimed that all vaccines undergo placebo-controlled trials before being licensed. Siri countered this assertion, pointing out that many childhood vaccines, including Rotateq, were not approved based on placebo-controlled trials. The debate revolves around using placebos in vaccine trials, particularly their role in assessing safety. Siri argued that using an active substance, like an aluminum adjuvant, instead of a saline placebo could skew safety evaluations. For instance, in the Gardasil vaccine trial, both the vaccine group and the control group experienced similar rates of harm due to using an active adjuvant in the control group.

Trending: Mugshot of Donald Trump

Further examples, like Prevnar 7 and Prevnar 13 vaccines, were provided to demonstrate the absence of accurate placebo controls in vaccine trials, potentially obscuring the actual safety profiles of these vaccines. The article highlights that Offit later revised his “All vaccines” claim to “Most vaccines” in response to the debate. The piece emphasizes the importance of rigorous placebo-controlled trials in vaccine safety assessment, particularly in light of the National Childhood Vaccine Injury Act’s limitations and pharmaceutical companies’ incentives.

The exchange underscores the need for transparent discussions about vaccine safety and the challenges in establishing causation between vaccine injury and adverse events without proper placebo controls. The article concludes by urging readers to critically evaluate information from health authorities and agencies, especially in the context of evolving public health measures and policies.